Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.

Zhang H, Kobayashi R, Galaktionov K, Beach D.

Cell. 1995 Sep 22;82(6):915-25.

2.

Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

Yu ZK, Gervais JL, Zhang H.

Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11324-9.

3.

TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.

Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H.

J Biol Chem. 2000 Oct 6;275(40):31145-54.

4.
5.

Association of the cell cycle regulatory proteins p45(SKP2) and CksHs1. Functional effect on CDK2 complex formation and kinase activity.

Mongay L, Plaza S, Vigorito E, Serra-Pagès C, Vives J.

J Biol Chem. 2001 Jul 6;276(27):25030-6. Epub 2001 May 10.

6.
7.
8.

Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.

Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, Slingerland JM, Amati B.

Oncogene. 1998 Nov 19;17(20):2637-43.

9.
10.

Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.

Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.

Oncogene. 2000 Nov 9;19(47):5314-23.

11.
12.

Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.

Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace AJ Jr, O'Connor PM.

Oncogene. 1996 Feb 1;12(3):595-607.

PMID:
8637717
13.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

14.

Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.

Xie G, Habbersett RC, Jia Y, Peterson SR, Lehnert BE, Bradbury EM, D'Anna JA.

Oncogene. 1998 Feb 12;16(6):721-36.

15.

v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.

Maclaren A, Clark W, Black EJ, Gregory D, Fujii H, Gillespie DA.

Oncogene. 2003 Apr 24;22(16):2383-95.

PMID:
12717415
16.

Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.

Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.

Oncogene. 1999 Apr 15;18(15):2441-50.

17.

A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.

Afshari CA, Nichols MA, Xiong Y, Mudryj M.

Cell Growth Differ. 1996 Aug;7(8):979-88.

18.

Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.

Yam CH, Ng RW, Siu WY, Lau AW, Poon RY.

Mol Cell Biol. 1999 Jan;19(1):635-45.

19.
20.

Formation of p27-CDK complexes during the human mitotic cell cycle.

Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.

Cell Growth Differ. 1996 Feb;7(2):135-46.

Supplemental Content

Support Center